MALAT1 and non-small cell lung carcinoma: Our results were similar to the findings of Yang et al., where they showed that knockout of MALAT1 via shRNA MALAT1 improved the apoptotic rate of Polyphyllin I promoted in gefitinib-resistant NSCLC (Yang et al., 2018).